NEW YORK – Stilla Technologies announced on Tuesday that it has raised €20 million ($22 million) in a Series B funding round.
The round includes a new investor, China-based TUS-Holdings. Stilla will use the funds to support development of a next-generation digital PCR platform and to expand in Asia.
In addition to TUS-Holding, funding in the round came from the firm's existing investors including Illumina Ventures, Kurma Partners, LBO France, Paris Saclay Seed Funds, BNP Paribas Développement, and Idinvest Partners.